No Win No Fee Medical Negligence Claims

If you think you may have been the victim of health care negligence contact our specialist solicitors now for free advice.

Get Instant, No Obligation Advice From Our Experts

Get a Free Claim Assessment

Please check your details before you submit this form. By submitting your details you confirm your agreement to our privacy policy

August 16, 2022

A New Research Has Been Launched Into Prostate Cancer In Nottingham

Nottingham University Hospital (NUH) said it hoped the PUR (Prostate Urine Risk) study would help pinpoint the best time for medical intervention.

Consultant Will Green has said there is an urgent need to improve diagnosis of prostate cancer and predict outcomes for patients as the Nottingham University Hospital launches a research into prostate cancer.

Research from the University of East Anglia is the basis for the new study.

'Important step'

A consultant urologist and principal investigator for the PUR study at Nottingham University Hospital- Mr Green said: "The dilemma for patients who are regarded as having 'low risk' prostate cancer is when to intervene. Most patients with low-risk prostate cancer demonstrate a disease process with a slow progression but some will progress unexpectedly and we need to identify them in the most efficient way possible. As prostate cancer is the most prevalent type of cancer in men in the UK, this makes it even more important."

Mr Green said that currently, men regarded as low risk were determined by something called the Gleason score which is used to predict how aggressive their cancer is.

He also added that prostate cancer is very complex and risk levels vary widely between each man. He then noted that urgent improvements need to be made in diagnosis and predicting outcomes for patients with prostate cancer.

Based on the pilot study in East Anglia, he said that the NUH was bringing in patients for a trial which will reveal which men who are considered at intermediate risk might require treatment urgently.

She added that the trial opening for recruitment in Nottingham was an important step forward.

In her words, "We hope that one day this could prevent men from undergoing unnecessary tests and treatments that cause more harm than good."

Do You Have Cancer Misdiagnosis Claims?

Patients are entitled to receive the right standard of care from their healthcare providers who owe them that duty of care. It is therefore a shame if a patient has his or her condition misdiagnosed which further leads to complications, injury, trauma or even death which could have been well avoided.

In such cases, you can turn to our NHS negligence solicitors for legal assistance. Our solicitors are well versed in different NHS claims and will undertake your claims with utmost dedication to ensure that you get a deserved justice.

Our cancer misdiagnosis claims are handled on a no win no fee basis also known as Conditional Fee Agreement. What this implies is that we will only take a pre-agreed percentage of your settlement payout if only the claim is successful. This therefore means that you are not at risk of any financial loss or debt in any way.

We would also like to inform you that except in certain special cases, you have only three years from the date you were aware of the negligent action to make a claim. It is also advised that you make your claims early enough to increase your chances of success.

Our helplines are displayed on the page; do well to reach out to us or fill out our online free enquiry form to get started.

No Win No Fee Medical Negligence Solicitors

Get a Free Claim Assessment

Please check your details before you submit this form. By submitting your details you confirm your agreement to our privacy policy

Get in touch! We can help with your claim!

Email Or Call us